Search
  • ryanjamesjessup

BioMolecular Imaging | Post-Project Consulting

Updated: Sep 14

Market opportunities and company valuation for companion diagnostics-therapeutics is an increasingly important area of needed experience which BioMolecular Imaging can provide.


This extends from the clinical rationale and utility of using diagnostics together with new or established therapeutics to the financial cost and benefits.


As a radiologist, Dr. J. James Frost is familiar with the main determinants of clinical utility and benefit and knows many clinical specialists, whom he can contact for their value opinion.


Routine clinical implementation of new diagnostic imaging agents requires an integrated strategy and thinking between the radiologist and the clinical specialist. This, in turn, requires a concrete understanding of the indications and criteria for ordering the test, clear reporting, and availability for follow-up consulting, when needed.



As a clinical radiologist and nuclear medicine physician, Dr. J. James Frost has been on the front lines of this process as new imaging methods have been progressively added to the armamentarium. In each case, there are growing pains that require care and diligence in management.


BioMolecular Imaging has provided chairs who’ve served on many pharmaceutical advisory boards. These boards steer the initial rollout of a new drug or diagnostic from communication to all the stakeholders, marketing, production and to financial monitoring.



About BioMolecular Imaging


BioMolecular Imaging (BMI Consultants) is a molecular imaging and clinical trial consultancy owned and operated by Dr. J. James Frost M.D./Ph.D out of Baltimore Maryland. BMI has been involved with clinical, therapeutic & diagnostic imaging focused on Oncology, Brain, Biomarkers, Cardiology and Central Image Interpretations for over 20 year


To learn more about BioMolecular Imaging, please visit https://www.BioMolecularImaging.com or connect with:


SoundCloud - https://soundcloud.com/BioMolecular-Imaging

Facebook - https://www.facebook.com/BMIConsultants

Twitter - https://twitter.com/BMIConsultants

LinkedIn - https://www.linkedin.com/company/BioMolecular-Imaging

YouTube - https://www.youtube.com/channel/UCkdv6cOQ8HunygNTtU66s2w


Copyright © 2022 BioMolecular Imaging


BioMolecular Imaging is a registered trademark of BioMolecular Imaging D.B.A. BMI Consultants

22 views0 comments

Recent Posts

See All

Diagnostic imaging is a core competency of BioMolecular Imaging - and is the approach of imaging the human body to analyze and form medical intervention, especially when viewing the function of organs

Imaging in therapeutic trials is the key process in expanding the understanding, methodology and metrics which are required to make determinations in drug targeting and efficacy. This spans most all i

A very active area of current investigation and commercialization is molecular and functional biomarker development. These biomarkers can serve as surrogate endpoints for therapeutic efficacy and are